[1] Moratorio G, Vignuzzi M. Monitoring and redirecting virus evolution. PLoS Pathog 2018;14(6):e1006979. http://dx.doi.org/10.1371/journal.ppat.1006979CrossRef
[2] Ladner JT, Grubaugh ND, Pybus OG, Andersen KG. Precision epidemiology for infectious disease control. Nat Med 2019;25(2):206 − 11. http://dx.doi.org/10.1038/s41591-019-0345-2CrossRef
[3] Lu J, du Plessis L, Liu Z, Hill V, Kang M, Lin HF, et al. Genomic epidemiology of SARS-CoV-2 in Guangdong province, China. Cell 2020;181(5):997 − 1003.e9. http://dx.doi.org/10.1016/j.cell.2020.04.023CrossRef
[4] Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019(COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020;25(10):2000180. http://dx.doi.org/10.2807/1560-7917.ES.2020.25.10.2000180CrossRef
[5] Wang YS, Kang HYJ, Liu XF, Tong ZH. Asymptomatic cases with SARS-CoV-2 infection. J Med Virol 2020;92(9):1401 − 3. http://dx.doi.org/10.1002/jmv.25990CrossRef
[6] Gardy JL, Loman NJ. Towards a genomics-informed, real-time, global pathogen surveillance system. Nat Rev Genet 2018;19(1):9 − 20. http://dx.doi.org/10.1038/nrg.2017.88CrossRef
[7] Oude Munnink BB, Nieuwenhuijse DF, Stein M, O’Toole Á, Haverkate M, Mollers M, et al. Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands. Nat Med 2020;26(9):1405 − 10. http://dx.doi.org/10.1038/s41591-020-0997-yCrossRef
[8] Grubaugh ND, Ladner JT, Kraemer MUG, Dudas G, Tan AL, Gangavarapu K, et al. Genomic epidemiology reveals multiple introductions of Zika virus into the United States. Nature 2017;546(7658):401 − 5. http://dx.doi.org/10.1038/nature22400CrossRef
[9] Rannala B, Yang ZH. Probability distribution of molecular evolutionary trees: a new method of phylogenetic inference. J Mol Evol 1996;43(3):304 − 11. http://dx.doi.org/10.1007/BF02338839CrossRef